KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to $19.9 million.

  • Petmed Express' Operating Expenses rose 2016.77% to $19.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $110.5 million, marking a year-over-year increase of 5264.33%. This contributed to the annual value of $70.7 million for FY2025, which is 2395.67% down from last year.
  • According to the latest figures from Q4 2025, Petmed Express' Operating Expenses is $19.9 million, which was up 2016.77% from $20.8 million recorded in Q3 2025.
  • Petmed Express' 5-year Operating Expenses high stood at $48.5 million for Q2 2025, and its period low was $11.1 million during Q3 2021.
  • Its 5-year average for Operating Expenses is $19.5 million, with a median of $17.9 million in 2022.
  • As far as peak fluctuations go, Petmed Express' Operating Expenses tumbled by 4600.1% in 2024, and later skyrocketed by 23127.43% in 2025.
  • Over the past 5 years, Petmed Express' Operating Expenses (Quarter) stood at $12.6 million in 2021, then surged by 37.86% to $17.3 million in 2022, then increased by 29.74% to $22.5 million in 2023, then dropped by 26.3% to $16.6 million in 2024, then rose by 20.17% to $19.9 million in 2025.
  • Its Operating Expenses was $19.9 million in Q4 2025, compared to $20.8 million in Q3 2025 and $48.5 million in Q2 2025.